Author:
Rothenberg Mace L.,Carbone David P.,Johnson David H.
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference42 articles.
1. Pharmaceutical Research and Manufacturers Association. Pharmaceutical Industry Primer 2001: A Century of Progress [online], (cited 7 Mar 2003), <
http://www.phrma.org/publications/publications//2001-07-09.508.pdf
> (1991).
2. Burris, H. A. et al. Improvements in survival and clinical benefit with gemcitabine as front-line therapy for patients with advanced pancreas cancer: a randomized trial. J. Clin. Oncol. 15, 2403–2413 (1997).
3. Rothenberg, M. L. et al. A multicenter phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal cancer. Cancer 85, 786–795 (1999).
4. Pitot, H. C. et al. Phase II trial of irinotecan in patients with metastatic colorectal carcinoma. J. Clin. Oncol. 15, 2910–2919 (1997).
5. Rougier, P. et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluororuracil failure in patients with metastatic colorectal cancer. Lancet 352, 1407–1412 (1998).
Cited by
138 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献